Racial Disparities in COVID-19 Testing and Outcomes: Retrospective Cohort Study in an Integrated Health System
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Racial disparities exist in outcomes after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. OBJECTIVE: To evaluate the contribution of race/ethnicity in SARS-CoV-2 testing, infection, and outcomes. DESIGN: Retrospective cohort study (1 February 2020 to 31 May 2020). SETTING: Integrated health care delivery system in Northern California. PARTICIPANTS: Adult health plan members. MEASUREMENTS: Age, sex, neighborhood deprivation index, comorbid conditions, acute physiology indices, and race/ethnicity; SARS-CoV-2 testing and incidence of positive test results; and hospitalization, illness severity, and mortality. RESULTS: Among 3 481 716 eligible members, 42.0% were White, 6.4% African American, 19.9% Hispanic, and 18.6% Asian; 13.0% were of other or unknown race. Of eligible members, 91 212 (2.6%) were tested for SARS-CoV-2 infection and 3686 had positive results (overall incidence, 105.9 per 100 000 persons; by racial group, White, 55.1; African American, 123.1; Hispanic, 219.6; Asian, 111.7; other/unknown, 79.3). African American persons had the highest unadjusted testing and mortality rates, White persons had the lowest testing rates, and those with other or unknown race had the lowest mortality rates. Compared with White persons, adjusted testing rates among non-White persons were marginally higher, but infection rates were significantly higher; adjusted odds ratios [aORs] for African American persons, Hispanic persons, Asian persons, and persons of other/unknown race were 2.01 (95% CI, 1.75 to 2.31), 3.93 (CI, 3.59 to 4.30), 2.19 (CI, 1.98 to 2.42), and 1.57 (CI, 1.38 to 1.78), respectively. Geographic analyses showed that infections clustered in areas with higher proportions of non-White persons. Compared with White persons, adjusted hospitalization rates for African American persons, Hispanic persons, Asian persons, and persons of other/unknown race were 1.47 (CI, 1.03 to 2.09), 1.42 (CI, 1.11 to 1.82), 1.47 (CI, 1.13 to 1.92), and 1.03 (CI, 0.72 to 1.46), respectively. Adjusted analyses showed no racial differences in inpatient mortality or total mortality during the study period. For testing, comorbid conditions made the greatest relative contribution to model explanatory power (77.9%); race only accounted for 8.1%. Likelihood of infection was largely due to race (80.3%). For other outcomes, age was most important; race only contributed 4.5% for hospitalization, 12.8% for admission illness severity, 2.3% for in-hospital death, and 0.4% for any death. LIMITATION: The study involved an insured population in a highly integrated health system. CONCLUSION: Race was the most important predictor of SARS-CoV-2 infection. After infection, race was associated with increased hospitalization risk but not mortality. PRIMARY FUNDING SOURCE: The Permanente Medical Group, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452 · cited 2×
“The CCI score (4) ranges from 0 to 40; increasing values indicate worsening comorbidity burden.”
BackgroundMethodComorbidity measures for use with administrative data.
Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998) · Medical Care · doi:10.1097/00005650-199801000-00004 · Cited by 9,921 · cited 3×
“We then scanned KPNC databases, linking members' records to the following data elements: self-reported race and ethnicity (captured by medical assistants in the outpatient setting, admission clerks for hospitalized patients, and/or at the time of KFHP enrollment); individual Elixhauser comorbid conditions (2) and the…”
MethodFactors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674 · cited 1×
“3 million patients but did not provide hospitalization data, reported increased COVID19–related mortality among non-White patients that persisted after risk adjustment (21).”
BackgroundStructural racism and health inequities in the USA: evidence and interventions
Bailey, Z. D., Krieger, N., Agénor, M., Graves, J., Linos, N., & Bassett, M. T. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30569-x · Cited by 5,203
van Walraven, C., Austin, P. C., Jennings, A., Quan, H., & Forster, A. J. (2009) · Medical Care · doi:10.1097/mlr.0b013e31819432e5 · Cited by 2,200 · cited 2×
“We then scanned KPNC databases, linking members' records to the following data elements: self-reported race and ethnicity (captured by medical assistants in the outpatient setting, admission clerks for hospitalized patients, and/or at the time of KFHP enrollment); individual Elixhauser comorbid conditions (2) and the…”
MethodHospitalization and mortality among Black patients and White patients with Covid-19.
Price-Haywood, E. G., Burton, J., Fort, D., & Seoane, L. (2020) · New England Journal of Medicine · doi:10.1056/nejmsa2011686 · Cited by 1,660 · cited 1×
“Like our study, articles providing risk-adjusted race- and ethnicityspecific mortality data in hospitalized patients with SARSCoV-2 infection have reported that the effect of race/ ethnicity is substantially decreased or even absent (20, 24).”
ResultRacial and Ethnic Disparities in Population-Level Covid-19 Mortality
Gross, C. P., Essien, U. R., Pasha, S., Gross, J. R., Wang, S.-Y., & Nunez-Smith, M. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06081-w · Cited by 410
Controlling Disease and Creating Disparities: A Fundamental Cause Perspective
Phelan, J. C., & Link, B. G. (2005) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/60.special_issue_2.s27 · Cited by 409
Cited by
Equitably Allocating Resources during Crises: Racial Differences in Mortality Prediction Models
Ashana, D. C., Anesi, G. L., Liu, V. X., Escobar, G. J., Chesley, C., Eneanya, N. D., Weissman, G. E., Miller, W. D., Harhay, M. O., & Halpern, S. D. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202012-4383oc · Cited by 98
Self-citationPritchett, J. C., Borah, B. J., Desai, A. P., Xie, Z., Saliba, A. N., Leventakos, K., Coffey, J. D., Pearson, K. K., Speicher, L. L., Orenstein, R., et al. (2021) · JCO Oncology Practice · doi:10.1200/op.21.00307 · Cited by 32
Metadata
- Authors
- Escobar, G. J., Adams, A. S., Liu, V. X., Soltesz, L., Chen, Y.-F. I., Parodi, S. M., Ray, G. T., Myers, L. C., Ramaprasad, C. M., Dlott, R., & Lee, C.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2021-06
- Volume
- 174
- Issue
- 6
- Pages
- 786-793
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W3128929332
- Cited by
- 166
- References
- 8
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Racial Disparities in COVID-19 Testing and Outcomes: Retrospective Cohort Study in an Integrated Health System. https://app.cochat.ai/papers/10.7326/m20-6979
- The paper
- Escobar, G. J., Adams, A. S., Liu, V. X., Soltesz, L., Chen, Y.-F. I., Parodi, S. M., Ray, G. T., Myers, L. C., Ramaprasad, C. M., Dlott, R., & Lee, C. (2021). Racial Disparities in COVID-19 Testing and Outcomes: Retrospective Cohort Study in an Integrated Health System. Annals of Internal Medicine. https://doi.org/10.7326/m20-6979
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.